Analysis of Debt

Gilead Sciences Inc., balance sheet: debt

US$ in millions

	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Current portion of long-term debt and other obligations, net	1,798)	2,273)	1,516)	2,757)	2,499)
Long-term debt, net, excluding current portion	23,189)	22,957)	25,179)	28,645)	22,094)
Total debt, net (carrying amount)	24,987)	25,230)	26,695)	31,402)	24,593)

Download chart

Debt item	Description	The company
Total debt, net (carrying amount)	Sum of the carrying values as of the balance sheet date of all debt plus capital lease obligations.	Gilead Sciences Inc. total debt decreased from 2021 to 2022 and from 2022 to 2023.

	Dec 31, 2023
Selected Financial Data (US$ in millions)
Senior unsecured notes	22,567)
Liability related to future royalties	1,230)
Total debt, net (fair value)	23,797)
Financial Ratio
Debt, fair value to carrying amount ratio	0.95

Weighted-average interest rate on debt: 3.91%

Interest rate	Debt amount¹	Interest rate × Debt amount
3.70%	1,750)	65)
3.50%	1,749)	61)
3.65%	2,744)	100)
2.95%	1,248)	37)
1.20%	747)	9)
1.65%	994)	16)
5.25%	992)	52)
4.60%	993)	46)
4.00%	743)	30)
2.60%	988)	26)
5.65%	996)	56)
4.80%	1,737)	83)
4.50%	1,734)	78)
4.75%	2,222)	106)
4.15%	1,729)	72)
2.80%	1,478)	41)
5.55%	988)	55)
Total	23,832)	933)
3.91%

¹ US$ in millions

² Weighted-average interest rate = 100 × 933 ÷ 23,832 = 3.91%

Gilead Sciences Inc. (NASDAQ:GILD)